Highlights from the SWG
The European Scientific foundation for Laboratory Hemato Oncology (ESLHO), together with the three scientific consortia of EuroClonality, EuroMRD, and EuroFlow, share the same four goals:
- Research and innovation of diagnostic patient care
- Standardization of laboratory diagnostics
- Quality assessment
- Education
ESLHO supports the three consortia in achieving these goals by performing a broad set of consortium management tasks. These include:
- Organization of meetings
- Representation at international conferences
- Financial administration
- Internal and external communication
- Support of work packages
- Support of quality assessment schemes
- Development of educational materials
- Support of patent prosecution processes
- Other valorization activities
Highlights from 2023
EHA2023 Congress
The SWG held a session at EHA2023, with presentations on the latest developments of our networks.
EuroFlow presentation
‘New developments in immune response monitoring: Identification of new subsets of innate myeloid cells’ by Cristina Teodosio.
EuroMRD presentation
‘MRD assessment in pediatric Ph+ALL reveals distinct biological subtypes with clinical consequences’ by Jan Zuna
EuroClonality presentation
‘New NGS applications for IG-TR gene studies’ by Mouhamad Khouja.
ISO accreditation
Currently, we are working to be ISO accredited for the EQA programs that EuroFlow, EuroMRD, and EuroClonality offer.
Annual meeting week
The three consortia met each other in November 2023 in Salamanca, Spain, during our annual meeting week.
A highlight of this week was the 12th ESLHO Symposium, at which several consortium participants presented exciting new developments in the field of hemato-oncology laboratory diagnostics.
From the many abstracts that were submitted, the Scientific Committee selected several for oral presentation.
The remaining abstracts were presented as posters during the poster session. Together, the EuroClonality, EuroMRD, and EuroFlow participants then ranked the posters, and the resulting winner was rewarded with the ESLHO poster prize.
ESLHO networks and Management Team
In 2023, we continued to further professionalize our ESLHO networks with extra attention for transparency and sustainability.
We also expanded the ESLHO Management Team. We did this due to:
- the gradual growth of the EuroClonality, EuroMRD, and EuroFlow consortia over the last decade
- an increase in the number of events and the demand for supporting activities
Three new members were added in 2023, bringing our total number of ESLHO Management Team members to five.
Publications
In 2023, we published ten publications on our collaborative work in peer-reviewed journals—all open access. You can find details and links on our publications page.
In addition, a new EuroFlow educational book on PID immunodeficiencies was published in 2023. This book contains twelve EuroFlow group publications that were published between 2018 and 2022.
Back